標(biāo)題: Titlebook: Chemoradiation in Cancer Therapy; Hak Choy Book 2003 Springer Science+Business Media New York 2003 breast cancer.cancer.carcinoma.chemothe [打印本頁] 作者: Conjecture 時間: 2025-3-21 16:27
書目名稱Chemoradiation in Cancer Therapy影響因子(影響力)
書目名稱Chemoradiation in Cancer Therapy影響因子(影響力)學(xué)科排名
書目名稱Chemoradiation in Cancer Therapy網(wǎng)絡(luò)公開度
書目名稱Chemoradiation in Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Chemoradiation in Cancer Therapy被引頻次
書目名稱Chemoradiation in Cancer Therapy被引頻次學(xué)科排名
書目名稱Chemoradiation in Cancer Therapy年度引用
書目名稱Chemoradiation in Cancer Therapy年度引用學(xué)科排名
書目名稱Chemoradiation in Cancer Therapy讀者反饋
書目名稱Chemoradiation in Cancer Therapy讀者反饋學(xué)科排名
作者: 起波瀾 時間: 2025-3-21 22:03 作者: 灰姑娘 時間: 2025-3-22 03:00 作者: reflection 時間: 2025-3-22 06:34 作者: 五行打油詩 時間: 2025-3-22 09:20 作者: Indicative 時間: 2025-3-22 14:39
The Role of Gemcitabine in Combined Modality Therapyon in pancreatic carcinoma, gemcitabine has been licensed for the treatment of nonsmall-cell lung cancer (NSCLC) .. The focus of this chapter will be to examine the current preclinical and clinical evidence probing the efficacy of gemcitabine as a clinically useful radiosensitizing agent. It will be作者: Indicative 時間: 2025-3-22 17:47 作者: 勤勉 時間: 2025-3-23 01:13
Combined Modality Strategies in the Treatment of Head and Neck Cancerr Society estimates that in the United States alone approx 40,300 new cases of HNC will be diagnosed annually with approx 11,700 deaths associated from this disease .. If cured, HNC patients are at increased risk of developing a second malignancy, estimated to occur at an annual incidence of 3–7% (3作者: Traumatic-Grief 時間: 2025-3-23 01:53
The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Cancer 131,000 new cases of nonsmall-cell lung cancer (NSCLC) diagnosed in 2000 will die from their disease .. The focus of this chapter is on the patients who present with locally advanced or stage III NSCLC (about 46,000 patients yearly). Although it is tempting to think of stage III NSCLC as a uniform 作者: 半身雕像 時間: 2025-3-23 07:37 作者: ALB 時間: 2025-3-23 10:54
The Role of Chemoradiation in the Management of Esophageal Cancermor registry data obtained from the Surveillance, Epidemiology, and End Results (SEER) program has shown a decrease in the age-adjusted incidence of squamous cell carcinoma, while there has been a steady increase in the incidence of adenocarcinoma. Since the mid-1970s the incidence of adenocarcinoma作者: zonules 時間: 2025-3-23 16:21
Chemoradiation in Therapy for Colon and Rectum Carcinomarall survival have been demonstrated with the use of combined-modality therapy in several randomized clinical trials performed over the past 25 yr. This chapter reviews the role of adjuvant chemotherapy and radiation therapy for colon and rectal cancer. Issues surrounding chemoradiation for rectal c作者: Psa617 時間: 2025-3-23 18:37
Chemoradiotherapy in Muscle-Invasive Bladder Cancernually. A majority of patients will present with nonmuscle-invasive disease, be treated adequately with transurethral resection (TURBT) with or without intravesical chemotherapy or immunotherapy, and will have only a 10–15% risk (higher for higher grades) of developing muscle-invasive disease. In co作者: craving 時間: 2025-3-24 00:18 作者: 小平面 時間: 2025-3-24 05:34
Fluoropyrimidines as Radiation Sensitizersction in local failure rates, eradication of micrometastases to enhance distant control, preservation of organ function, and decrease in tumor bulk prior to surgery to make complete resection possible and improve survival.作者: Mortar 時間: 2025-3-24 07:52
Combined Modality Treatment of Small-Cell Lung Cancer port. LD accounts for approx 40% of all SCLC cases. Extensive-stage disease (ED) is tumor spread beyond these boundaries .. The presence of pleural effusions and/or supraclavicular lymphadenopathy have been considered LD by some investigators and ED by others.作者: Culpable 時間: 2025-3-24 14:07 作者: archaeology 時間: 2025-3-24 17:58 作者: 大量殺死 時間: 2025-3-24 19:00 作者: Factual 時間: 2025-3-24 23:13
2196-9906 multimodality approach to the management of solid tumors and speculate on possible future strategies for chemoradiation therapy. The authors detail applications of combined modality therapy in lung, esophageal, breast, gastric, pancreatic, colon, and rectal cancers. They also show how radiation int作者: Inculcate 時間: 2025-3-25 07:03 作者: semiskilled 時間: 2025-3-25 10:13
Lebensphasen am Beispiel des Alters,to examine the current preclinical and clinical evidence probing the efficacy of gemcitabine as a clinically useful radiosensitizing agent. It will begin by examining the mechanism of action of the drug itself at a cellular and molecular level.作者: 合唱隊 時間: 2025-3-25 12:08 作者: Detain 時間: 2025-3-25 19:09
Warum eine qualitative Evaluation?,t intravesical chemotherapy or immunotherapy, and will have only a 10–15% risk (higher for higher grades) of developing muscle-invasive disease. In contradistinction, the natural history of muscle-invasive disease is much more aggressive, with a 5-yr survival of only 50%.作者: Substitution 時間: 2025-3-25 23:33
ChemoradiationDNA where it acts through the formation of free radicals to directly or indirectly cause double-stranded breaks. It is these double-stranded breaks in the DNA that are felt to be the lethal lesion that malignant cells sustain from therapeutic radiation.作者: recession 時間: 2025-3-26 03:00
The Role of Gemcitabine in Combined Modality Therapyto examine the current preclinical and clinical evidence probing the efficacy of gemcitabine as a clinically useful radiosensitizing agent. It will begin by examining the mechanism of action of the drug itself at a cellular and molecular level.作者: MINT 時間: 2025-3-26 07:48
Chemoradiation in Therapy for Colon and Rectum Carcinomais chapter reviews the role of adjuvant chemotherapy and radiation therapy for colon and rectal cancer. Issues surrounding chemoradiation for rectal cancer, including sphincter preservation, total mesorectal excision, local excision, and newer chemotherapy agents, are also discussed.作者: 舊石器時代 時間: 2025-3-26 10:02 作者: defile 時間: 2025-3-26 15:16
Lebensphasen am Beispiel des Alters,ction in local failure rates, eradication of micrometastases to enhance distant control, preservation of organ function, and decrease in tumor bulk prior to surgery to make complete resection possible and improve survival.作者: 不容置疑 時間: 2025-3-26 17:21
Wo kann sich die ?Soziale Stadt“ verorten? port. LD accounts for approx 40% of all SCLC cases. Extensive-stage disease (ED) is tumor spread beyond these boundaries .. The presence of pleural effusions and/or supraclavicular lymphadenopathy have been considered LD by some investigators and ED by others.作者: 雪崩 時間: 2025-3-26 23:45 作者: 類人猿 時間: 2025-3-27 03:09
Lebensphasen am Beispiel des Alters,al-regional control and overall survival (Table 1). Radiation sensitization with these agents is dose and schedule dependent and additional knowledge about this combination treatment, based on new laboratory data, may help optimize the use of the CPTs as radiosensitizers.作者: Mets552 時間: 2025-3-27 05:34 作者: fatty-acids 時間: 2025-3-27 09:56 作者: grudging 時間: 2025-3-27 13:48
Camptothecin Radiation Sensitizational-regional control and overall survival (Table 1). Radiation sensitization with these agents is dose and schedule dependent and additional knowledge about this combination treatment, based on new laboratory data, may help optimize the use of the CPTs as radiosensitizers.作者: COKE 時間: 2025-3-27 20:30
Combined Modality Strategies in the Treatment of Head and Neck Cancerre aerodigestive tract, resulting in cumulative toxicity to a large mucosal surface .. S qua-mous cell carcinomas constitute >90% of the histology of head and neck carcinomas. Therefore, this chapter will focus solely on this histology type unless specified otherwise.作者: 引起痛苦 時間: 2025-3-28 00:31
The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Canceranging from potentially resectable T3N1 (small T3 and microscopically involved N1 lymph node) to unresectable, locally advanced T4N3 disease (large primary invading mediastinal structures and contralateral mediastinal adenopathy) ..作者: 初學(xué)者 時間: 2025-3-28 05:17
Book 2003f solid tumors and speculate on possible future strategies for chemoradiation therapy. The authors detail applications of combined modality therapy in lung, esophageal, breast, gastric, pancreatic, colon, and rectal cancers. They also show how radiation interacts with such chemotherapeutic agents as作者: 我要威脅 時間: 2025-3-28 07:20 作者: 充氣女 時間: 2025-3-28 12:16
Lebensphasen am Beispiel des Alters,nt that appear to have promising activities in the completed preclinical studies. They include taxoltere metro ., the epothilones ., and the BMS compounds 184476 and 188797 .. This chapter will provide an overview of the current status of the taxanes and their combination with radiation in the treat作者: UTTER 時間: 2025-3-28 17:55 作者: 抵押貸款 時間: 2025-3-28 19:31 作者: 騷擾 時間: 2025-3-29 02:35 作者: rheumatism 時間: 2025-3-29 05:49
Taxanes in Combined Modality Therapynt that appear to have promising activities in the completed preclinical studies. They include taxoltere metro ., the epothilones ., and the BMS compounds 184476 and 188797 .. This chapter will provide an overview of the current status of the taxanes and their combination with radiation in the treat作者: 指數(shù) 時間: 2025-3-29 08:24
Chemoradiation Strategies for Patients with Malignant GliomasGBM and AA with standard therapeutic approaches are 10–12 mo and 30–40 mo, respectively .. Genetic characteristics of primary brain tumors have been correlated with treatment response and clinical outcomes as shown by Cairncross et al., who demonstrated that allelic loss of chromosome 1p predicted i作者: 排他 時間: 2025-3-29 12:56 作者: defibrillator 時間: 2025-3-29 17:51 作者: 鋸齒狀 時間: 2025-3-29 21:15
Hak ChoyIncludes supplementary material: 作者: attenuate 時間: 2025-3-30 01:31 作者: Stress-Fracture 時間: 2025-3-30 05:54 作者: Handedness 時間: 2025-3-30 08:50 作者: 喃喃訴苦 時間: 2025-3-30 15:32 作者: 起皺紋 時間: 2025-3-30 20:35 作者: 成份 時間: 2025-3-30 20:56 作者: 卷發(fā) 時間: 2025-3-31 00:59 作者: LINES 時間: 2025-3-31 08:52 作者: Encoding 時間: 2025-3-31 11:53
Lebensphasen am Beispiel des Alters,r Society estimates that in the United States alone approx 40,300 new cases of HNC will be diagnosed annually with approx 11,700 deaths associated from this disease .. If cured, HNC patients are at increased risk of developing a second malignancy, estimated to occur at an annual incidence of 3–7% (3作者: prediabetes 時間: 2025-3-31 16:08
Lebensstile in der quartiersforschung 131,000 new cases of nonsmall-cell lung cancer (NSCLC) diagnosed in 2000 will die from their disease .. The focus of this chapter is on the patients who present with locally advanced or stage III NSCLC (about 46,000 patients yearly). Although it is tempting to think of stage III NSCLC as a uniform 作者: single 時間: 2025-3-31 18:15 作者: abnegate 時間: 2025-4-1 01:12 作者: 啤酒 時間: 2025-4-1 01:53
Qualitative Evaluation in sieben Schritten,rall survival have been demonstrated with the use of combined-modality therapy in several randomized clinical trials performed over the past 25 yr. This chapter reviews the role of adjuvant chemotherapy and radiation therapy for colon and rectal cancer. Issues surrounding chemoradiation for rectal c
